Centene ( ($CNC) ) has released its Q2 earnings. Here is a breakdown of the information Centene presented to its investors. Centene Corporation is ...

The story has been updated with executive comment and stock price change Healthcare insurance giant Centene Corporation (NYSE ...

Discover Centene Corporation's Q2 2025 earnings analysis, uncovering setbacks, repricing strategies, and plans for profitability restoration.

Centene is responding by repricing plans for 2026 and focusing on cost controls while Medicare Advantage and Prescription ...

Centene on Friday posted a surprise quarterly loss, in yet another disappointment for investors in the sector that has suffered a series of setbacks due to rising costs in government-backed insurance ...

Analysts have given Centene a total of 16 ratings, with the consensus rating being Neutral. The average one-year price target is $49.62, indicating a potential 68.66% upside.